Followers | 3 |
Posts | 251 |
Boards Moderated | 0 |
Alias Born | 04/23/2013 |
Tuesday, March 19, 2019 12:31:52 PM
Eg: Nyloxin failed to meet the government standards for an opioid replacement: Double-blind, placebo-controlled, published and peer-reviewed studies.
Proof: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143940654
In another post, I even stated, I've been through it myself.
Those who took me seriously are not unhappy today.
Thinking
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM